{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:10:46Z","timestamp":1784632246641,"version":"3.55.0"},"reference-count":63,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,10,16]]},"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The Scleroderma Patient-centered Intervention Network\u2014Scleroderma Support group Leader EDucation (SPIN-SSLED) Programme was designed to improve confidence and self-efficacy and to reduce burden for support group leaders. Objectives were to (1) evaluate feasibility of programme delivery, including required resources, management issues and scientific aspects (eg, performance of outcome measures) and (2) assess user satisfaction and identify any modifications needed to improve programme content or delivery based on participant feedback.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Non-randomised feasibility trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>North American patient organisations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Current support group leaders or potential new leaders referred by patient organisations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>The programme included 13 modules delivered live via videoconference over 3 months (April to July 2018) in 60 to 90\u2009min sessions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>(1) Elements of feasibility, including enrolment and consent procedures, percentage of referred group leaders who consented to participate, session attendance and technical support requirements; (2) programme usability, understandability, organisation and clarity; (3) leader satisfaction with the programme and (4) planned trial outcome measures, including support group leader self-efficacy, burnout, emotional distress and physical function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All 12 referred potential participants consented to enrol, and 10 were included in two training groups of five participants each. Participants attended 95% of sessions. Required technical support was minimal, and videoconferencing technology functioned well. Overall programme satisfaction rating was 9.4\/10. Mean item rating on the eight items of the Client Satisfaction Questionnaire-8 was 3.83 (1=low satisfaction; 4=high satisfaction). Pre-post scores on the Scleroderma Support Group Leader Self-efficacy Scale increased by 1.7 SDs (large effect); scores on burnout, emotional distress and physical function improved by 0.44, 0.38 and 0.45 SDs (moderate effects).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The SPIN-SSLED Programme was feasibly delivered, including management, resource and scientific aspects. Participant satisfaction was high. The programme is ready to be tested in a full-scale randomised controlled trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03508661\">NCT03508661<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2019-029935","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T04:55:43Z","timestamp":1573534543000},"page":"e029935","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Scleroderma Patient-centered Intervention Network\u2014Scleroderma Support group Leader EDucation (SPIN-SSLED) program: non-randomised feasibility trial"],"prefix":"10.1136","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct03508661","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03508661","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5644-8432","authenticated-orcid":false,"given":"Brett D","family":"Thombs","sequence":"first","affiliation":[{"name":"Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Qu\u00e9bec, Canada"},{"name":"Department of Psychiatry, McGill University, Montreal, Qu\u00e9bec, Canada"},{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada"},{"name":"Department of Medicine, McGill University, Montreal, Quebec, Canada"},{"name":"Department of Psychology, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dyas","sequence":"additional","affiliation":[{"name":"Scleroderma Foundation Michigan Chapter, Southfield, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"P\u00e9pin","sequence":"additional","affiliation":[{"name":"Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylene","family":"Aguila","sequence":"additional","affiliation":[{"name":"Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Eve","family":"Carrier","sequence":"additional","affiliation":[{"name":"Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Tao","sequence":"additional","affiliation":[{"name":"Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Harb","sequence":"additional","affiliation":[{"name":"Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa L","family":"Malcarne","sequence":"additional","affiliation":[{"name":"Department of Psychology, San Diego State University, San Diego, California, USA"},{"name":"San Diego Joint Doctoral Program in Clinical Psychology, San Diego State University\/University of California, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan","family":"El-Baalbaki","sequence":"additional","affiliation":[{"name":"Department of Psychology, Universit\u00e9 du Qu\u00e9bec \u00e0 Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pel\u00e1ez","sequence":"additional","affiliation":[{"name":"Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Qu\u00e9bec, Canada"},{"name":"Department of Educational and Counselling Psychology, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Sauve","sequence":"additional","affiliation":[{"name":"Scleroderma Society of Ontario, Scleroderma Canada, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Hudson","sequence":"additional","affiliation":[{"name":"Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Qu\u00e9bec, Canada"},{"name":"Department of Medicine, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W","family":"Platt","sequence":"additional","affiliation":[{"name":"Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Qu\u00e9bec, Canada"},{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"key":"2025121220510149000_9.11.e029935.1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2648.2000.02254.x"},{"key":"2025121220510149000_9.11.e029935.2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1300\/J013v23n03_03","article-title":"Role strain and psychological well-being in women with systemic lupus erythematosus","volume":"23","author":"Karasz","year":"1995","journal-title":"Women Health"},{"key":"2025121220510149000_9.11.e029935.3","unstructured":"Kole A , Faurisson F . The voice of 12,000 patients: experiences and expectations of rare disease patients on diagnosis and care in Europe, 2009. Available: http:\/\/www.eurordis.org\/IMG\/pdf\/voice_12000_patients\/EURORDISCARE_FULLBOOKr.pdf [Accessed 10 Feb 2019]."},{"key":"2025121220510149000_9.11.e029935.4","unstructured":"European Organisation for Rare Diseases . Rare diseases: understanding this public health priority, 2005. Available: http:\/\/www.eurordis.org\/IMG\/pdf\/princeps_document-EN.pdf [Accessed 10 Feb 2019]."},{"key":"2025121220510149000_9.11.e029935.5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/ajmg.a.33380","article-title":"Quality of life in rare genetic conditions: a systematic review of the literature","volume":"152A","author":"Cohen","year":"2010","journal-title":"Am J Med Genet A"},{"key":"2025121220510149000_9.11.e029935.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-7625.2009.00552.x"},{"key":"2025121220510149000_9.11.e029935.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2004.02.010"},{"key":"2025121220510149000_9.11.e029935.8","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-015-0324-8","article-title":"Unmet needs for healthcare and social support services in patients with Huntington's disease: a cross-sectional population-based study","volume":"10","author":"van Walsem","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"2025121220510149000_9.11.e029935.9","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-8-22","article-title":"Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support","volume":"8","author":"Anderson","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"2025121220510149000_9.11.e029935.10","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-9-83","article-title":"Identifying the unmet health needs of patients with congenital hypogonadotropic hypogonadism using a web-based needs assessment: implications for online interventions and peer-to-peer support","volume":"9","author":"Dwyer","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"2025121220510149000_9.11.e029935.11","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2014.44"},{"key":"2025121220510149000_9.11.e029935.12","doi-asserted-by":"publisher","DOI":"10.1177\/1527154411404243"},{"key":"2025121220510149000_9.11.e029935.13","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0140-6736(04)17277-2","article-title":"Self-Management interventions for chronic illness","volume":"364","author":"Newman","year":"2004","journal-title":"The Lancet"},{"key":"2025121220510149000_9.11.e029935.14","doi-asserted-by":"publisher","DOI":"10.1037\/0003-066X.55.2.205"},{"key":"2025121220510149000_9.11.e029935.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003563","article-title":"The scleroderma patient-centered intervention network (spin) cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context","volume":"3","author":"Kwakkenbos","year":"2013","journal-title":"BMJ Open"},{"key":"2025121220510149000_9.11.e029935.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-007-0382-8"},{"key":"2025121220510149000_9.11.e029935.17","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1080\/09638288.2017.1416497","article-title":"Reasons for attending support groups and organizational preferences: the European scleroderma support group members survey","volume":"41","author":"Gumuchian","year":"2019","journal-title":"Disabil Rehabil"},{"key":"2025121220510149000_9.11.e029935.18","first-page":"56","article-title":"Reasons for non-participation in scleroderma support groups","volume":"100","author":"Delisle","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2025121220510149000_9.11.e029935.19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/acr.23220","article-title":"Reasons for not participating in scleroderma patient support groups: a cross\u2010sectional study","volume":"70","author":"Gumuchian","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2025121220510149000_9.11.e029935.20","first-page":"1","article-title":"Training and support needs of scleroderma support group facilitators: the North American scleroderma support group facilitators survey","volume":"25","author":"Delisle","year":"2018","journal-title":"Disabil Rehabil"},{"key":"2025121220510149000_9.11.e029935.21","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/S0140-6736(08)60875-2","article-title":"Empowerment of patients: lessons from the rare diseases community","volume":"371","author":"Aym\u00e9","year":"2008","journal-title":"The Lancet"},{"key":"2025121220510149000_9.11.e029935.22","doi-asserted-by":"publisher","DOI":"10.1053\/sonu.2001.25946"},{"key":"2025121220510149000_9.11.e029935.23","unstructured":"Seibold J . Scleroderma. In: Harris ED , Budd RC , Firestein GS , eds. Kelly\u2019s Textbook of Rheumatology. Philadelphia: Elsevier, 2005: 1279\u2013308."},{"key":"2025121220510149000_9.11.e029935.24","doi-asserted-by":"crossref","unstructured":"Mayes M . Systemic sclerosis: clinical features. In: Klippel JH , Stone JH , Crafford LJ , eds. Primer on the rheumatic diseases. 13th edn. New York: Springer and Arthritis Foundation, 2008: 343\u201350.","DOI":"10.1007\/978-0-387-68566-3_17"},{"key":"2025121220510149000_9.11.e029935.25","unstructured":"Wigley FM , Hummers LK . Clinical features of systemic sclerosis. In: Hochberg MC , Silman AJ , Smolen JS , eds. Rheumatology. 3rd edn. Philadelphia: Mosby, 2003: 1463\u201380."},{"key":"2025121220510149000_9.11.e029935.26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rdc.2015.04.010","article-title":"Psychosocial aspects of scleroderma","volume":"41","author":"Kwakkenbos","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"2025121220510149000_9.11.e029935.27","unstructured":"Scleroderma Canada . Find a support group. Available: www.scleroderma.ca\/Support\/Find-A-Support-Group.php [Accessed 10 Feb 2019]."},{"key":"2025121220510149000_9.11.e029935.28","unstructured":"Scleroderma Foundation . Support groups. Available: www.scleroderma.org\/site\/PageServer?pagename=patients_supportgroups#.Vbec7RZvdFw [Accessed 10 Feb 2019]."},{"key":"2025121220510149000_9.11.e029935.29","unstructured":"Scleroderma & Raynaud\u2019s UK . Find support. Available: www.sruk.co.uk\/find-support\/ [Accessed 10 Feb 2019]."},{"key":"2025121220510149000_9.11.e029935.30","unstructured":"Scleroderma Association of New South Wales . Regional support groups. Available: www.sclerodermansw.org\/regional-support-groups [Accessed 10 Feb 2019]."},{"key":"2025121220510149000_9.11.e029935.31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013325","article-title":"Effect of support group peer facilitator training programmes on peer facilitator and support group member outcomes: a systematic review","volume":"6","author":"Delisle","year":"2016","journal-title":"BMJ Open"},{"key":"2025121220510149000_9.11.e029935.32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jcop.21677","article-title":"Supporting the supporters: a randomized controlled trial of interventions to assist the leaders of cancer support groups","volume":"43","author":"Zordan","year":"2015","journal-title":"J Community Psychol"},{"key":"2025121220510149000_9.11.e029935.33","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i5239","article-title":"Consort 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"2025121220510149000_9.11.e029935.34","unstructured":"Boud D , Feletti G . The challenge of problem-based learning. 2nd edn. London: Kogan Page, 1997."},{"key":"2025121220510149000_9.11.e029935.35","unstructured":"Duch BJ , Groh SE , Allen DE . Why problem-based learning? A case study of institutional change in undergraduate education. In: Duch BJ , Groh SE , Allen DE , eds. The power or problem-based learning. Sterling, VA: Stylus, 2001: 3\u201311."},{"key":"2025121220510149000_9.11.e029935.36","doi-asserted-by":"publisher","DOI":"10.1023\/B:EDPR.0000034022.16470.f3"},{"key":"2025121220510149000_9.11.e029935.37","unstructured":"Torp L , Sage S . Problems as possibilities: problem-based learning for K-16 education. 2nd edn. Alexandria, VA: Association for Supervision and Curriculum Development, 2002."},{"key":"2025121220510149000_9.11.e029935.38","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.rasd.2013.07.022","article-title":"Training discrete trials teaching skills using videoconference","volume":"7","author":"Hay-Hansson","year":"2013","journal-title":"Res Autism Spectr Disord"},{"key":"2025121220510149000_9.11.e029935.39","first-page":"232","article-title":"Improving learning outcomes: integration of standardized patients & telemedicine technology","volume":"25","author":"Seibert","year":"2004","journal-title":"Nurs Educ Perspect"},{"key":"2025121220510149000_9.11.e029935.40","doi-asserted-by":"publisher","DOI":"10.1258\/135763307780907996"},{"key":"2025121220510149000_9.11.e029935.41","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/46.3.398"},{"key":"2025121220510149000_9.11.e029935.42","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.rasd.2014.05.002","article-title":"Preliminary findings of a randomized clinical trial of a virtual training program for applied behavior analysis technicians","volume":"8","author":"Fisher","year":"2014","journal-title":"Res Autism Spectr Disord"},{"key":"2025121220510149000_9.11.e029935.43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2015.05.013","article-title":"The telehealth enhancement of adherence to medication (team) in pediatric IBD trial: design and methodology","volume":"43","author":"Hommel","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"2025121220510149000_9.11.e029935.44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejon.2016.08.008","article-title":"Addressing behavioral impacts of childhood leukemia: a feasibility pilot randomized controlled trial of a group videoconferencing parenting intervention","volume":"24","author":"Williams","year":"2016","journal-title":"Eur J Oncol Nurs"},{"key":"2025121220510149000_9.11.e029935.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2014.05.027"},{"key":"2025121220510149000_9.11.e029935.46","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5301\/jsrd.5000260","article-title":"Development and preliminary validation of the scleroderma support group leader self-efficacy scale","volume":"3","author":"Pal","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"key":"2025121220510149000_9.11.e029935.47","first-page":"168","article-title":"Development of the group leader self-efficacy instrument","volume":"26","author":"Page","year":"2001","journal-title":"JSGW"},{"key":"2025121220510149000_9.11.e029935.48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1369-7625.2010.00592.x","article-title":"Exploring the impact of training on the experience of Australian support group leaders: current practices and implications for research","volume":"13","author":"Zordan","year":"2010","journal-title":"Health Expect"},{"key":"2025121220510149000_9.11.e029935.49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1300\/J010v42n02_03","article-title":"Sustaining leaders of cancer support groups: the role, needs, and difficulties of leaders","volume":"42","author":"Butow","year":"2005","journal-title":"Soc Work Health Care"},{"key":"2025121220510149000_9.11.e029935.50","first-page":"296","article-title":"The convergent validity of two burnout instruments: a multitrait-multimethod analysis","volume":"18","author":"Demerouti","year":"2002","journal-title":"Eur J Psychol Assess"},{"key":"2025121220510149000_9.11.e029935.51","doi-asserted-by":"publisher","DOI":"10.1080\/02678370500340728"},{"key":"2025121220510149000_9.11.e029935.52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.burn.2014.11.001","article-title":"Measuring job and academic burnout with the Oldenburg burnout inventory (OLBI): factorial invariance across samples and countries","volume":"2","author":"Reis","year":"2015","journal-title":"Burn Res"},{"key":"2025121220510149000_9.11.e029935.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.06.026"},{"key":"2025121220510149000_9.11.e029935.54","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep443"},{"key":"2025121220510149000_9.11.e029935.55","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/rheumatology\/kex055","article-title":"Performance of the patient-reported outcomes measurement information System-29 in scleroderma: a scleroderma patient-centered intervention network cohort study","volume":"56","author":"Kwakkenbos","year":"2017","journal-title":"Rheumatology"},{"key":"2025121220510149000_9.11.e029935.56","doi-asserted-by":"publisher","DOI":"10.1016\/0149-7189(79)90094-6"},{"key":"2025121220510149000_9.11.e029935.57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/dar.12522","article-title":"The client satisfaction Questionnaire-8: psychometric properties in a cross-sectional survey of people attending residential substance abuse treatment","volume":"37","author":"Kelly","year":"2018","journal-title":"Drug Alcohol Rev"},{"key":"2025121220510149000_9.11.e029935.58","unstructured":"Cohen J . Statistical Power Analysis for the Behavioral Sciences. 2nd edn. Hillsdale, NJ: Lawrence Erlbaum, 1988."},{"key":"2025121220510149000_9.11.e029935.59","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a2390","article-title":"Improving the reporting of pragmatic trials: an extension of the CONSORT statement","volume":"337","author":"Zwarenstein","year":"2008","journal-title":"BMJ"},{"key":"2025121220510149000_9.11.e029935.60","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.316.7127.285","article-title":"Understanding controlled trials: what are pragmatic trials?","volume":"316","author":"Roland","year":"1998","journal-title":"BMJ"},{"key":"2025121220510149000_9.11.e029935.61","unstructured":"Lohr S , Schochet PZ , Sanders E . Partially nested randomised controlled trials in educational research: a guide to design and analysis. NCER 2014-2000. Washington, DC: National Center for Education Research, 2014."},{"key":"2025121220510149000_9.11.e029935.62","doi-asserted-by":"publisher","DOI":"10.1080\/00273170802034810"},{"key":"2025121220510149000_9.11.e029935.63","first-page":"268","article-title":"Intention-To-Treat analysis in partially nested randomized controlled trials with real-world complexity","volume":"39","author":"Schweig","year":"2016","journal-title":"IJRES"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-029935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T04:51:13Z","timestamp":1765601473000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-029935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":63,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,11]]},"published-print":{"date-parts":[[2019,11]]}},"alternative-id":["10.1136\/bmjopen-2019-029935"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-029935","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}